Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Haemonetics Corporation (HAE) had Weighted-Average Shares Outstanding (Diluted) of 46.22M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$346.35M |
|
$-20.15M |
|
$148.14M |
|
$198.21M |
|
$369.38M |
|
$-23.02M |
|
$-5.37M |
|
$-28.40M |
|
$-28.40M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-20.15M |
|
$-23.02M |
|
-- |
|
46.22M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
46.22M |
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$834.88M |
|
$305.76M |
|
$1.56B |
|
$2.40B |
|
$282.60M |
|
$1.22B |
|
$1.32B |
|
$1.60B |
|
-- |
|
$-307.70M |
|
$796.32M |
|
-- |
|
| Cash Flow Statement Financials | |
$293.22M |
|
$-179.55M |
|
$-178.46M |
|
$306.76M |
|
$245.44M |
|
$-61.32M |
|
$33.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|